Published in J Infect Dis on November 01, 1998
Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev (2003) 2.90
Stage-stratified approach to AIDS-related Kaposi's sarcoma: implications for resource-limited environments. J Clin Oncol (2014) 1.41
HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma. J Med Virol (2008) 1.05
Reflections on the interpretation of heterogeneity and strain differences based on very limited PCR sequence data from Kaposi's sarcoma-associated herpesvirus genomes. J Clin Virol (2007) 0.86
Genetic diversity of the Kaposi's sarcoma herpesvirus K1 protein in AIDS-KS in Zimbabwe. J Clin Virol (2008) 0.85
Human herpesvirus 8 (HHV8) sequence variations in HHV8 related tumours in Okinawa, a subtropical island in southern Japan. J Clin Pathol (2004) 0.81
Molecular analysis of human herpesvirus 8 by using single nucleotide polymorphisms in open reading frame 26. J Clin Microbiol (2003) 0.81
Genotypic distribution of HHV-8 in AIDS individuals without and with Kaposi sarcoma: Is genotype B associated with better prognosis of AIDS-KS? Medicine (Baltimore) (2016) 0.75
Effect of electrochemotherapy on human herpesvirus 8 kinetics in classic Kaposi sarcoma. Infect Agent Cancer (2017) 0.75
Human herpesvirus 8 group B and C variants circulating in São Paulo, Brazil. J Infect Dis (1998) 1.83
Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med (2001) 5.31
Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals. J Virol (1997) 2.75
European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis (2011) 2.47
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? J Infect Dis (2004) 2.26
Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. JAMA (1996) 1.94
Two allelic genes responsible for vegetative incompatibility in the fungus Podospora anserina are not essential for cell viability. Mol Gen Genet (1991) 1.88
Detection of Mycoplasma pneumoniae and Mycoplasma genitalium in clinical samples by polymerase chain reaction. Clin Infect Dis (1993) 1.82
A Tn1545-like transposon carries the tet(M) gene in tetracycline resistant strains of Bacteroides ureolyticus as well as Ureaplasma urealyticum but not Neisseria gonorrhoeae. J Antimicrob Chemother (1996) 1.63
Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1999) 1.62
SACRAL syndrome: spinal dysraphism, anogenital, cutaneous, renal and urologic anomalies, associated with an angioma of lumbosacral localization. Dermatology (2007) 1.60
Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene). J Clin Microbiol (2001) 1.56
Oat sensitization in children with atopic dermatitis: prevalence, risks and associated factors. Allergy (2007) 1.45
Short- and medium-term efficacy of specific hydrotherapy in inherited ichthyosis. Br J Dermatol (2011) 1.44
Microbiological diagnosis of vertebral osteomyelitis: relevance of second percutaneous biopsy following initial negative biopsy and limited yield of post-biopsy blood cultures. Eur J Clin Microbiol Infect Dis (2013) 1.44
Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients. J Clin Microbiol (1995) 1.39
Hepatitis C virus infection with and without cryoglobulinemia as a case of Churg-Strauss syndrome. J Rheumatol (2000) 1.39
Plasma lipids in HIV-infected patients: a prospective study in 95 patients. Eur J Clin Invest (1994) 1.39
Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004. HIV Med (2007) 1.36
HIV-1 sensitivity to zidovudine: a consensus culture technique validated by genotypic analysis of the reverse transcriptase. J Virol Methods (1992) 1.34
Multicenter evaluating of a commercially available PCR assay for diagnosing enterovirus infection in a panel of cerebrospinal fluid specimens. J Clin Microbiol (1996) 1.32
Four common glomulin mutations cause two thirds of glomuvenous malformations ("familial glomangiomas"): evidence for a founder effect. J Med Genet (2005) 1.30
Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.25
[Letter: Hypoglycemia after perhexiline maleate]. Nouv Presse Med (1975) 1.21
[Hematologic and immunologic manifestations of primary cytomegalovirus infections in non-immunocompromised hospitalized adults]. Rev Med Interne (2000) 1.21
The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or beta-carotene. Am J Clin Nutr (1996) 1.20
Tuberculosis in patients infected with human immunodeficiency virus 1. A retrospective multicentre study of 123 cases in France. The Groupe des Infectiologues du Sud de la France. Q J Med (1992) 1.20
A hospital outbreak of gastroenteritis possibly related to the contamination of tap water by a small round structured virus. J Hosp Infect (1999) 1.17
Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol (2011) 1.17
Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients. HIV Med (2005) 1.15
Latency and reactivation of JC virus in peripheral blood of human immunodeficiency virus type 1-infected patients. J Clin Microbiol (1997) 1.14
Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients. HIV Med (2004) 1.13
Progression of human immunodeficiency virus infection in patients with tuberculosis disease. A cohort study in Bordeaux, France, 1988-1994. The Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA). Am J Epidemiol (1997) 1.13
Wild-mushroom intoxication as a cause of rhabdomyolysis. N Engl J Med (2001) 1.12
In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients. Antimicrob Agents Chemother (1990) 1.11
Disseminated Mycobacterium lentiflavum infection in a human immunodeficiency virus-infected patient. J Clin Microbiol (2001) 1.11
Engineering pathways for malate degradation in Saccharomyces cerevisiae. Nat Biotechnol (1997) 1.11
Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors. J Acquir Immune Defic Syndr (2001) 1.10
Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine. Clin Infect Dis (2000) 1.09
Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapy. J Clin Microbiol (1998) 1.08
Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France. HIV Med (2009) 1.08
Devic's neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus. Lupus (1999) 1.07
Prospective follow-up of complications related to peripherally inserted central catheters. Med Mal Infect (2013) 1.04
Detection of JC virus DNA in the peripheral blood leukocytes of HIV-infected patients. AIDS (1996) 1.02
[In vitro sensitivity of Mycobacterium avium and Mycobacterium xenopi to erythromycin, roxithromycin and doxycycline]. Pathol Biol (Paris) (1989) 1.01
Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the delta lamivudine roll-over study. Antivir Ther (1999) 1.01
Further ultrastructural observations of virus morphogenesis and myelin pathology in JHM virus encephalomyelitis. Neuropathol Appl Neurobiol (1980) 1.01
[Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology]. Cancer Radiother (2001) 1.00
Polycythaemia as a complication of transdermal testosterone therapy. Br J Haematol (2000) 1.00
Prolonged shedding of influenza A(H1N1)v virus: two case reports from France 2009. Euro Surveill (2009) 1.00
Quantitation of HIV-1 RNA in dried blood and plasma spots. J Virol Methods (2009) 0.98
Idiopathic aseptic facial granuloma (pyodermite froide du visage): a pediatric entity? Arch Dermatol (2001) 0.97
Highly active antiretroviral treatment initiated early in the course of symptomatic primary HIV-1 infection: results of the ANRS 053 trial. J Infect Dis (1999) 0.97
Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability. AIDS Care (2011) 0.97
Soluble adhesion molecules and endothelial cell damage in HIV infected patients. Thromb Haemost (1997) 0.97
Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients. AIDS Res Hum Retroviruses (1997) 0.96
[Anterior uveitis and cidofovir]. J Fr Ophtalmol (2001) 0.96
Pandemic influenza A(H1N1) 2009: molecular characterisation and duration of viral shedding in intensive care patients in Bordeaux, south-west France, May 2009 to January 2010. Euro Surveill (2011) 0.95
Peripheral neuropathy with essential mixed cryoglobulinemia: biopsies from 5 cases. Acta Neuropathol (1988) 0.94
Serum selenium predicts outcome in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.93
In vitro infection of human macrophages with human T-cell leukemia virus type 1. Blood (1993) 0.93
Spontaneous splenic rupture: an uncommon complication of cytomegalovirus infection. J Infect (1994) 0.93
Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses. J Antimicrob Chemother (2013) 0.92
Increases in CD3+CD4-CD8- T lymphocytes in AIDS patients with disseminated Mycobacterium avium-intracellulare complex infection. J Infect Dis (1996) 0.92
Usefulness of a global clinical ichthyosis vulgaris scoring system for predicting common FLG null mutations in an adult caucasian population. Br J Dermatol (2012) 0.92
Potential improvements in therapeutic options for mycoplasmal respiratory infections. Clin Infect Dis (1993) 0.91
Qualitative and quantitative molecular detection of enteroviruses in water from bathing areas and from a sewage treatment plant. Res Microbiol (2001) 0.91
JC virus remains latent in peripheral blood B lymphocytes but replicates actively in urine from AIDS patients. J Infect Dis (1998) 0.91
HIV type 1 Thai subtype E is predominant in South Vietnam. AIDS Res Hum Retroviruses (1996) 0.91